Artículos del autor

solaci

Day 3

NOBORI II: Final 5-year results of drug-eluting stent with bio-absorbable polymer

This study evaluated the performance of Nobori biolimus bio-absorbable polymer stent in real-world patients. A total of...
solaci -
Day 3

SOURCE XT: Results at 2 years of SAPIEN XT valve

Multicenter prospective study included 2688 patients with a mean age of 81.4 years and 20.5 EuroScore. The...
solaci -
Day 3

UK TAVI Registry: Long-term results of TAVI in the UK

This record has been created in order to evaluate the results of percutaneous aortic valve replacement in...
solaci -
Day 3

DISCOVER Trial: Results at one year of the new nonmetallic percutaneous aortic valve

Direct Flow Medical prosthesis is a nonmetallic, repositionable, recaptured valve (even after posts dilate), that does not...
solaci -
Day 3

POST -IT: The FFR modifies strategy in almost half of patients

The use of FFR to guide treatment showed improved outcomes in previous studies. However, there are few...
solaci -
Day 3

TRYTON dedicated bifurcation stent in left main coronary artery

TRYTON is a cobalt chromium device specifically dedicated for bifurcation lesions to be implanted in the side...
solaci -
Day 3

REDUCE-HTN: safety and efficacy of new bipolar device for renal denervation

This study included 146 patients with resistant hypertension who were medicated with an average of 5.4 drugs....
solaci -
Day 3

ADVANCE II: Low incidence of permanent pacemaker for self -expandable valve

The incidence of permanent pacemaker implantation (PPM) is variable between the different series within 30 days of...
solaci -